Searching the RRID Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Resource Name
PDF Report How to cite
Memorial Sloan Kettering Cancer Center Biotherapeutics Core Facility (RRID:SCR_027797)
Copy Citation Copied
Resource Information

URL: https://www.mskcc.org/research/ski/core-facilities/biotherapeutics

Proper Citation: Memorial Sloan Kettering Cancer Center Biotherapeutics Core Facility (RRID:SCR_027797)

Description: Core provides collaborative process development support to investigators across the Center engaged in new Biotherapeutics initiatives. Core staff are responsible for converting research-lab processes into GMP-compliant manufacturing processes. This includes establishing Standard Operating Procedures (SOPs) and batch records for cell processing, cell engineering, and vector production. Provides full support for cGMP manufacturing of cell products: handling patient cells in cGMP environment, from purification and transduction to expansion and formulation, for use in phase 1 and phase 2 clinical trials. Manufactures vector stocks, oversees biosafety and releases testing of generated projects for human use. This includes analysis of patient cells and vector stocks, assessing characteristics such as phenotype, potency, purity, and stability. Gene transfer and expression analyses are also performed. Core performs analytical post-infusion monitoring. For each trial, the Core develops a comprehensive set of analytical tests to ensure quality and safety of the manufactured drug products.

Resource Type: core facility, access service resource, service resource

Keywords: ABRF, new Biotherapeutics initiatives services, establishing Standard Operating Procedures, batch records, cell processing, cell engineering, vector production, procedures, manufactures vector stocks, oversees biosafety and releases testing,

Expand All
This resource

is listed by

ABRF CoreMarketplace

has parent organization

Memorial Sloan Kettering Cancer Center

Usage and Citation Metrics

We found {{ ctrl2.mentions.all_count }} mentions in open access literature.

We have not found any literature mentions for this resource.

We are searching literature mentions for this resource.

Most recent articles:

{{ mention._source.dc.creators[0].familyName }} {{ mention._source.dc.creators[0].initials }}, et al. ({{ mention._source.dc.publicationYear }}) {{ mention._source.dc.title }} {{ mention._source.dc.publishers[0].name }}, {{ mention._source.dc.publishers[0].volume }}({{ mention._source.dc.publishers[0].issue }}), {{ mention._source.dc.publishers[0].pagination }}. (PMID:{{ mention._id.replace('PMID:', '') }})

Checkfor all resource mentions.

Collaborator Network

A list of researchers who have used the resource and an author search tool

Find mentions based on location


{{ ctrl2.mentions.errors.location }}

A list of researchers who have used the resource and an author search tool. This is available for resources that have literature mentions.

Ratings and Alerts

No rating or validation information has been found for Memorial Sloan Kettering Cancer Center Biotherapeutics Core Facility.

No alerts have been found for Memorial Sloan Kettering Cancer Center Biotherapeutics Core Facility.

Data and Source Information